476 related articles for article (PubMed ID: 16313843)
41. Estrogen and angiotensin II interactions determine cardio-renal damage in Dahl salt-sensitive rats with heart failure.
Hoshi-Fukushima R; Nakamoto H; Imai H; Kanno Y; Ishida Y; Yamanouchi Y; Suzuki H
Am J Nephrol; 2008; 28(3):413-23. PubMed ID: 18097133
[TBL] [Abstract][Full Text] [Related]
42. Activation of angiotensin II-forming chymase in the cardiomyopathic hamster heart.
Shiota N; Fukamizu A; Takai S; Okunishi H; Murakami K; Miyazaki M
J Hypertens; 1997 Apr; 15(4):431-40. PubMed ID: 9211178
[TBL] [Abstract][Full Text] [Related]
43. Protection against ischemia/reperfusion injury and myocardial dysfunction by antisense-oligodeoxynucleotide directed at angiotensin-converting enzyme mRNA.
Chen H; Mohuczy D; Li D; Kimura B; Phillips MI; Mehta P; Mehta JL
Gene Ther; 2001 May; 8(10):804-10. PubMed ID: 11420645
[TBL] [Abstract][Full Text] [Related]
44. Strain differences in angiotensin-converting enzyme and angiotensin II type I receptor expression. Possible implications for experimental chronic renal transplant failure.
Smit-van Oosten A; Henning RH; van Goor H
J Renin Angiotensin Aldosterone Syst; 2002 Mar; 3(1):46-53. PubMed ID: 11984748
[TBL] [Abstract][Full Text] [Related]
45. Angiotensin II formation in the intact human heart. Predominance of the angiotensin-converting enzyme pathway.
Zisman LS; Abraham WT; Meixell GE; Vamvakias BN; Quaife RA; Lowes BD; Roden RL; Peacock SJ; Groves BM; Raynolds MV
J Clin Invest; 1995 Sep; 96(3):1490-8. PubMed ID: 7657820
[TBL] [Abstract][Full Text] [Related]
46. Myocardial infarction increases ACE2 expression in rat and humans.
Burrell LM; Risvanis J; Kubota E; Dean RG; MacDonald PS; Lu S; Tikellis C; Grant SL; Lew RA; Smith AI; Cooper ME; Johnston CI
Eur Heart J; 2005 Feb; 26(4):369-75; discussion 322-4. PubMed ID: 15671045
[TBL] [Abstract][Full Text] [Related]
47. RNA interference targeting the ACE gene reduced blood pressure and improved myocardial remodelling in SHRs.
He J; Bian Y; Gao F; Li M; Qiu L; Wu W; Zhou H; Liu G; Xiao C
Clin Sci (Lond); 2009 Feb; 116(3):249-55. PubMed ID: 18605985
[TBL] [Abstract][Full Text] [Related]
48. Angiotensin II formation in the human heart: an ACE or non-ACE-mediated pathway?
Kokkonen JO; Saarinen J; Kovanen PT
Ann Med; 1998 Aug; 30 Suppl 1():9-13. PubMed ID: 9800878
[TBL] [Abstract][Full Text] [Related]
49. Acute kidney injury in the rat causes cardiac remodelling and increases angiotensin-converting enzyme 2 expression.
Burchill L; Velkoska E; Dean RG; Lew RA; Smith AI; Levidiotis V; Burrell LM
Exp Physiol; 2008 May; 93(5):622-30. PubMed ID: 18223026
[TBL] [Abstract][Full Text] [Related]
50. Regression of hypertrophy after myocardial infarction is produced by the chronic blockade of angiotensin type 1 receptor in rats.
Makino N; Hata T; Sugano M; Dixon IM; Yanaga T
J Mol Cell Cardiol; 1996 Mar; 28(3):507-17. PubMed ID: 9011634
[TBL] [Abstract][Full Text] [Related]
51. [Dynamic changes of angiotensin II type-1 receptor mRNA expression in volume-overloaded ventricular hypertrophy].
Li YQ; Gao GD; Chu YL; Gong XH
Sheng Li Xue Bao; 1998 Jun; 50(3):303-8. PubMed ID: 11324571
[TBL] [Abstract][Full Text] [Related]
52. Possible roles of cardiac chymase after myocardial infarction in hamster hearts.
Jin D; Takai S; Yamada M; Sakaguchi M; Yao Y; Miyazaki M
Jpn J Pharmacol; 2001 Jun; 86(2):203-14. PubMed ID: 11459123
[TBL] [Abstract][Full Text] [Related]
53. [Effects of losartan on the levels of angiotensin II and its type-1 receptor in diabetic rat kidney].
Wu W; Ding HL; Chen LH; Fu ZZ
Nan Fang Yi Ke Da Xue Xue Bao; 2006 Dec; 26(12):1742-4. PubMed ID: 17259110
[TBL] [Abstract][Full Text] [Related]
54. Radioligand binding reveals chymase as the predominant enzyme for mediating tissue conversion of angiotensin I in the normal human heart.
Katugampola SD; Davenport AP
Clin Sci (Lond); 2002 Jan; 102(1):15-21. PubMed ID: 11749656
[TBL] [Abstract][Full Text] [Related]
55. Simvastatin therapy normalizes sympathetic neural control in experimental heart failure: roles of angiotensin II type 1 receptors and NAD(P)H oxidase.
Gao L; Wang W; Li YL; Schultz HD; Liu D; Cornish KG; Zucker IH
Circulation; 2005 Sep; 112(12):1763-70. PubMed ID: 16157767
[TBL] [Abstract][Full Text] [Related]
56. Chronic blocking of beta 3-adrenoceptor ameliorates cardiac function in rat model of heart failure.
Gan RT; Li WM; Xiu CH; Shen JX; Wang X; Wu S; Kong YH
Chin Med J (Engl); 2007 Dec; 120(24):2250-5. PubMed ID: 18167212
[TBL] [Abstract][Full Text] [Related]
57. Chymase inhibitor improves survival in hamsters with myocardial infarction.
Hoshino F; Urata H; Inoue Y; Saito Y; Yahiro E; Ideishi M; Arakawa K; Saku K
J Cardiovasc Pharmacol; 2003 Jan; 41 Suppl 1():S11-8. PubMed ID: 12688390
[TBL] [Abstract][Full Text] [Related]
58. Role of chymase-dependent angiotensin II formation in monocrotaline-induced pulmonary hypertensive rats.
Kishi K; Jin D; Takai S; Muramatsu M; Katayama H; Tamai H; Miyazaki M
Pediatr Res; 2006 Jul; 60(1):77-82. PubMed ID: 16690960
[TBL] [Abstract][Full Text] [Related]
59. [Protection of captopril against chronic lung disease induced by hyperoxia in neonatal rats].
Li JJ; Xue XD
Zhongguo Dang Dai Er Ke Za Zhi; 2007 Apr; 9(2):169-73. PubMed ID: 17448318
[TBL] [Abstract][Full Text] [Related]
60. The chymase-angiotensin system in humans: biochemistry, molecular biology and potential role in cardiovascular diseases.
Liao Y; Husain A
Can J Cardiol; 1995 Aug; 11 Suppl F():13F-19F. PubMed ID: 7664213
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
